Chemoth.com
Chemoth is ranked 173,531 in the United Kingdom. 'Chemotherapy for Cancer Treatment | Types of Chemotherapy Agents ..'
173,531Rank in United Kingdom
4,554,907Worldwide Rank
| Monthly pages viewed | 2,705 | |
| Monthly visits | 2,705 | |
| Value per visitor | £0.13 | |
| Estimated worth | £1,283.25 | |
| External links | 27 | |
| Number of pages | 240 |
Last Updated: 05/04/2018 . Estimated data, read disclaimer.
Visitors
| Traffic History 90 Day Average | ||
| Worldwide Rank | 3,827,653 |  -7,140,021 |
|---|---|---|
| Daily Visitors | 66 | +300% |
| Daily Visitors Rank | 3,328,837 | -6,204,365 |
| Daily Pageviews | 0 | +400% |
| Daily Pageviews Rank | 5,279,603 | -8,267,791 |
| Pageviews Per User | 1.30 | +30% |
Content
www.Chemoth.com
- Popular pages
- chemoth.com Alkylating Chemotherapy Agents – Platinums, Mustards, and other ..
- chemoth.com Mathematical Models for Cancer Growth
- chemoth.com Allergies and Allergic Reactions to Chemotherapy Drugs
- chemoth.com The Philosophy of Combination Chemotherapy
On average 1.30 pages are viewed each, by the estimated 73 daily visitors.
Links- Links out
- clinicaltrials.gov Home - ClinicalTrials.gov
- eortc.be EORTC
- diythemes.com The Thesis Statement — Tips for Running a Successful, Profitable
- fda.gov Fast Track, Accelerated Approval and Priority Review
It has 2 DNS records, dns2.midphase.com, and dns1.midphase.com. Chemoth.com's IP address is 174.127.110.175.
IP: 174.127.110.175
| PING (174.127.110.175) 56(84) bytes of data. | |
| 64 bytes from slan-550-85.anhosting.com (174.127.110.175): icmp_seq=1 ttl=52 | 54.5 ms |
| 64 bytes from slan-550-85.anhosting.com (174.127.110.175): icmp_seq=2 ttl=52 | 54.3 ms |
| 64 bytes from slan-550-85.anhosting.com (174.127.110.175): icmp_seq=3 ttl=52 | 54.4 ms |
| --- ping statistics --- | |
| 3 packets transmitted, 3 received, 0% packet loss, time 1999ms | |
| rtt min/avg/max/mdev = 54.313/54.452/54.565/0.289 ms | |
| rtt min/avg/max/mdev = 54.313/54.452/54.565/0.289 ms |
Pinging the server, resulted in a 54.5 ms response.